CVE-2024-42176

LOW
2025-03-19 [email protected]
2.6
CVSS 3.1

CVSS Vector

CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:L/I:N/A:N
Attack Vector
Network
Attack Complexity
High
Privileges Required
Low
User Interaction
Required
Scope
Unchanged
Confidentiality
Low
Integrity
None
Availability
None

Lifecycle Timeline

2
Analysis Generated
Mar 28, 2026 - 18:32 vuln.today
CVE Published
Mar 19, 2025 - 15:15 nvd
LOW 2.6

Description

HCL MyXalytics is affected by concurrent login vulnerability. A concurrent login vulnerability occurs when simultaneous active sessions are allowed for a single credential allowing an attacker to potentially obtain access to a user's account or sensitive information.

Analysis

HCL MyXalytics is affected by concurrent login vulnerability. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Technical Context

This vulnerability is classified under CWE-307. HCL MyXalytics is affected by concurrent login vulnerability. A concurrent login vulnerability occurs when simultaneous active sessions are allowed for a single credential allowing an attacker to potentially obtain access to a user's account or sensitive information. Affected products include: Hcltech Dryice Myxalytics.

Affected Products

Hcltech Dryice Myxalytics.

Remediation

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.

Priority Score

13
Low Medium High Critical
KEV: 0
EPSS: +0.1
CVSS: +13
POC: 0

Share

CVE-2024-42176 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy